Bullseye Biosciences develops an in-cell drug discovery platform that uses directed evolution to identify functional molecules against challenging intracellular targets, including protein–protein interactions and transcriptional regulators
Bullseye Biosciences develops an in-cell drug discovery platform that uses directed evolution to identify functional molecules against challenging intracellular targets, including protein–protein interactions and transcriptional regulators. Its platform supports discovery of molecular glues, interaction-disrupting molecules, and other intracellularly active scaffolds, with programs spanning oncology, immunology, and other disease areas.